Cycloruthenated Self-Assembly with Metabolic Inhibition to Efficiently Overcome Multidrug Resistance in Cancers

Cycloruthenated Self-Assembly with Metabolic Inhibition to Efficiently Overcome Multidrug Resistance in Cancers

© 2021 The Seventh Affiliated Hospital, Sun Yat-Sen University. Advanced Materials published by Wiley-VCH GmbH.

Détails bibliographiques
Publié dans:Advanced materials (Deerfield Beach, Fla.). - 1998. - 34(2022), 1 vom: 01. Jan., Seite e2100245
Auteur principal: Li, Jia (Auteur)
Autres auteurs: Zeng, Leli, Wang, Zheng, Chen, Hengxing, Fang, Shuo, Wang, Jinquan, Cai, Chao-Yun, Xing, Enming, Liao, Xinxing, Li, Zhi-Wei, Ashby, Charles R Jr, Chen, Zhe-Sheng, Chao, Hui, Pan, Yihang
Format: Article en ligne
Langue:English
Publié: 2022
Accès à la collection:Advanced materials (Deerfield Beach, Fla.)
Sujets:Journal Article antitumor agents cyclometalated ruthenium complexes metabolism inhibition multidrug resistance self-assembly ATP Binding Cassette Transporter, Subfamily G, Member 2 Antineoplastic Agents Doxorubicin 80168379AG
Accès en ligne Volltext